Galapagos

Vitalnext brings together the worlds of Life Sciences and consumer products. We develop products with evidence-based health benefits for the ageing population. Healthy Ageing is an important topic in most societies throughout the world. The increasing life expectancy of most people creates a demand for products that keeps us in good health for prolonged periods of time. These products are commercialized via distribution- or licensing agreements with specialized business partners. Vitalnext’s most advanced product is an innovative medical nutrition that aims to not only improve body weight in malnourished people, but also improves the body composition in these patients by a preferential increase in muscle mass.

Cangenix provides a range of crystallographic and biophysical techniques, such as surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC), using tailored biological reagents to accelerate the understanding of compound-target interactions and utilize structural, kinetic and thermodynamic data to inform drug design.

Argenta Discovery is a privately held contract research drug discovery company.

ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. With more than 300 people employed by the Company, ProStrakan is headquartered in Scotland with commercial operations throughout the rest of the UK and continental Europe and a US head office. The Company's Development group is located in Galashiels, Scotland and Bedminster, New Jersey, US.

Inpharmatica specialises in the use of predictive informatics in medicinal chemistry and ADME to improve the speed and productivity of drug discovery. Founded in 1998, the company employs around 35 professionals at its UK locations in London and Cambridge. Inpharmatica’s unique proprietary technologies and skills are utilised in major discovery laboratories worldwide and use natural materials for health. Inpharmatica is unique in offering discovery technologies and services which span the full breadth of research from target through to candidate selection: the core elements are fully integrated, enabling customers to access its end-to-end technologies, or individual components and services as required.

BioFocus DPI Ltd develops gene-to-candidate drug discovery products and provides services to biotech, pharma, and patient and non-profit organizations.